- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Type 1 Diabetes Mellitus With Hyperglycemia in Hong Kong
Total 279 results
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Hong Kong, China, Malaysia
-
BIOTRONIK Asia Pacific Pte LtdCompletedMyocardial Ischemia | Coronary Artery Disease | Diabetes Mellitus Type 1 or 2China, India, Malaysia, Vietnam, Sri Lanka
-
University of SydneyNational Health and Medical Research Council, Australia; Mylan Pharmaceuticals... and other collaboratorsRecruitingDiabetic Retinopathy | Diabetic Nephropathies | Type 1 Diabetes MellitusAustralia, Hong Kong, New Zealand
-
SanofiCompletedType 2 Diabetes MellitusArgentina, Colombia, Egypt, Hong Kong, India, Indonesia, Lebanon, Malaysia, Peru, Philippines, Saudi Arabia, South Africa, Thailand, Turkey
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesMalaysia, Australia, Taiwan, Thailand, Hong Kong, Singapore, Philippines
-
TakedaCompletedType 2 Diabetes Mellitus | Essential HypertensionTaiwan, Thailand, China
-
Novo Nordisk A/SCompletedComparison of Human Insulin Produced by the Current Process and the NN729 Process in Type 1 DiabetesDiabetes | Diabetes Mellitus, Type 1Malaysia, Australia, Hong Kong, Philippines
-
PfizerTerminatedDiabetes Mellitus, Type 2Singapore, Hong Kong, Philippines, Pakistan
-
International Diabetes Institute, AustraliaGlaxoSmithKlineCompletedType 2 Diabetes MellitusChina, Indonesia, Korea, Republic of, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam
-
TakedaTerminatedDiabetes Mellitus, Type 2China, Hong Kong
-
SanofiCompletedType 2 Diabetes MellitusChina, Hong Kong, Malaysia, Thailand
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusChina, Argentina, Mexico
-
University of MichiganMahidol University; Fogarty International Center of the National Institute...CompletedType 2 Diabetes MellitusThailand
-
Eli Lilly and CompanyCompleted
-
Zhujiang HospitalNational Natural Science Foundation of ChinaRecruitingColorectal Cancer | Inflammatory Bowel Disease | Type2 Diabetes Mellitus | Atherosclerotic Cardiovascular DiseaseChina
-
PegBio Co., Ltd.RecruitingType 2 Diabetes Mellitus (T2DM)China, Taiwan, Hong Kong
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesMalaysia, South Africa, Hong Kong, Taiwan, Philippines
-
AstraZenecaCompletedHypertension | Type 2 DiabetesVietnam
-
Regeneron PharmaceuticalsBayerActive, not recruitingType 2 Diabetes Mellitus | Diabetic Macular Edema | Type 1 Diabetes MellitusUnited States, Puerto Rico, Japan, United Kingdom, Canada, Czechia, Germany, Hungary
-
TakedaCompletedDiabetes Mellitus, Type 2Hong Kong, China, Taiwan
-
Chromaderm, Inc.CompletedDiabetic Neuropathies | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Insulin-DependentCanada, United States, Croatia, Finland, India, Lithuania, Netherlands, United Kingdom
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Netherlands, Portugal, Spain, India, Austria, Egypt, Greece, Israel, Mexico, United Kingdom, Korea, Republic of, Hong Kong, Colombia, Lebanon
-
Hoffmann-La RocheTerminatedDiabetes Mellitus Type 2China, Hong Kong, Korea, Republic of, Philippines, Taiwan, Malaysia, Thailand
-
Medtronic DiabetesRecruitingType 2 Diabetes Treated With InsulinUnited States
-
US Department of Veterans AffairsAmerican Diabetes AssociationCompletedType 2 Diabetes MellitusUnited States
-
NovartisCompletedType 2 Diabetes MellitusGermany, Romania, Hungary, Belgium, Slovakia, Australia, India, Czech Republic, Guatemala, Hong Kong, United Kingdom
-
SanofiCompletedType 2 Diabetes MellitusChina, Korea, Republic of, Malaysia, Taiwan
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Austria, Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Denmark, Ecuador, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Italy, Malaysia, Mexico, Netherlands, Norway, Peru, Poland, Russian Federation and more
-
Novo Nordisk A/SCompletedDiabetes | Type 2 Diabetes MellitusTaiwan, Turkey, India, Algeria, Hong Kong, China, Ukraine
-
SanofiCompletedType 1 Diabetes MellitusUnited States, Canada, Czech Republic, Denmark, Estonia, Finland, Hungary, Japan, Latvia, Netherlands, Puerto Rico, Romania, Sweden
-
Abbott Diabetes CareCompletedType 2 Diabetes MellitusUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesHong Kong, China
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Netherlands, Portugal, Spain, Turkey, India, Austria, Egypt, Greece, Israel, Mexico, United Kingdom, Korea, Republic of, Hong Kong, Colombia, Lebanon
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Hong Kong, Romania, Mexico, United States, Bulgaria, Germany, Latvia, Lithuania, Guatemala
-
US Department of Veterans AffairsCompletedType 2 Diabetes MellitusUnited States
-
University of OxfordBayerCompletedCoronary Heart Disease | Acute Coronary Syndrome | Impaired Glucose Tolerance | Type 2 Diabetes Mellitus (T2DM)China, Hong Kong
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesKorea, Republic of
-
Southern California Institute for Research and...RecruitingNon-Alcoholic Fatty Liver Disease | Non Insulin Dependent Diabetes | ALTUnited States
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Hong Kong, Spain, United States, Mexico, Russian Federation, Guatemala, United Kingdom, Brazil
-
Mylan Inc.Mylan GmbHCompletedType 1 DiabetesUnited States, Canada, Czechia, Estonia, Germany, Hungary, Latvia, Romania, Slovakia, South Africa, United Kingdom
-
Astellas Pharma Korea, Inc.CompletedType 2 Diabetes MellitusKorea, Republic of
-
AstraZenecaTerminatedType 2 DiabetesItaly, Poland, South Africa, Malaysia, Hungary, Belgium, Slovakia, Philippines, Thailand, Hong Kong
-
Mannkind CorporationCompletedType 1 Diabetes MellitusUnited States, Brazil, Russian Federation, Ukraine
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Italy, Hong Kong, Romania, Greece, United States, Mexico, Serbia, Russian Federation
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Taiwan, China, Korea, Republic of
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusChina, Korea, Republic of, Taiwan
-
PfizerCompletedDiabetic NephropathyUnited States, Spain, Korea, Republic of, Australia, Hong Kong, Germany, Poland, Italy, Canada, Puerto Rico, Malaysia, Romania, Argentina, Peru
-
SanofiTerminatedSleep Initiation and Maintenance DisordersUnited States, Canada, Brazil, Russian Federation, Australia, Germany, Italy, Spain, Turkey, India, Malaysia, Singapore, Belgium, Czech Republic, Mexico, Argentina, Austria, Colombia, Chile, South Africa, United Kingdom, Hong Kong
-
Dong-A Pharmaceutical Co., Ltd.UnknownDiabetes Mellitis Type 2Korea, Republic of